The CIIC maintains a broad portfolio of clinical trials for both haematological malignancies and solid tumours.
In haematological malignancies, our portfolio features numerous NIHR Cancer Research Network-linked trials involving Birmingham-based Chief Investigators. In solid tumours, our portfolio focusses on diverse approaches (eg use of immunomodulatory drugs, vaccination approaches, and stratified approaches) in range of disease settings. Haematological and solid tumour programmes maintain close interactions with the CRCTU Early phase Drug Development team, and have enabled us to develop several National Cancer Research Institute-badged national trials in Birmingham.
To view our clinical trials for haematological malignancies, click here.
To view our clinical trials for solid tumours, click here.